지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
초록· 키워드
오류제보하기
Objectives：The purpose of this study was to investigate the prevalence and clinical characteristics of pseudoakathisia in schizophrenic in-patients who were receiving stable dosage of haloperidol or chlorpromazine. In particular, we sought to examine the relationship of pseudoakathisia to parkinsonism and tardive dyskinesia(TD).
Methods：The subjects were 110 in-patients aged between 18 and 60. The diagnosis and subtypes of akathisia were made according to the criteria of Barnes Akathisia Rating Scale(BARS). Pseudoakathisia was diagnosed if the score on the subjective awareness of restlessness item of the BARS was 0 and the score on the objective motor manifestation item of the BARS was 1 or more. Drug-induced parkinsonism and TD were evaluated using the Simpson-Angus Scale(SAS) and the Abnormal Involuntary Movement Scale(AIMS), respectively. Schizophrenic symptoms were assessed using the Manchester Scale. The prevalence of pseudoakathisia was examined, and the clinical variables were compared among the pseudoakathisia, true akathisia, and non-akathisia groups. The correlations between the symptomatology of akathisia and the other extrapyramidal motor signs were also evaluated.
Results：The prevalence of pseudoakathisia was found to be 8.2%(9/110). Three out of 9 patients with pseudoakathisia had both parkinsonism and TD, and 4 patients had only pseudoakathisia without being accompanied by other movement disorders. The demographic variables and the Manchester Scale score were not different among the groups. No significant group differences were found regarding the concurrence rate of parkinsonism or TD. In correlation analysis, BARS motor manifestation score was significantly correlated with AIMS total and limb-truncal dyskinesia scores, but not with AIMS orofacial dyskinesia score and SAS total score. Subjective restlessness score of BARS was significantly correlated with SAS total score but not with AIMS scores.
Conclusion：The results of the present study showed that the prevalence of pseudoakathisia in chronic schizophrenic in-patients receiving haloperidol or chlorpromazine was 8.2%. In clinical characteristics, pseudoakathisia with both parkinsonism and TD may exist. The relationship between pseudoakathisia and TD may be relatively limited. Further studies are required to elucidate more detailed characteristics of pseudoakathisia, and to examine its relationship with various clinical variables.
Methods：The subjects were 110 in-patients aged between 18 and 60. The diagnosis and subtypes of akathisia were made according to the criteria of Barnes Akathisia Rating Scale(BARS). Pseudoakathisia was diagnosed if the score on the subjective awareness of restlessness item of the BARS was 0 and the score on the objective motor manifestation item of the BARS was 1 or more. Drug-induced parkinsonism and TD were evaluated using the Simpson-Angus Scale(SAS) and the Abnormal Involuntary Movement Scale(AIMS), respectively. Schizophrenic symptoms were assessed using the Manchester Scale. The prevalence of pseudoakathisia was examined, and the clinical variables were compared among the pseudoakathisia, true akathisia, and non-akathisia groups. The correlations between the symptomatology of akathisia and the other extrapyramidal motor signs were also evaluated.
Results：The prevalence of pseudoakathisia was found to be 8.2%(9/110). Three out of 9 patients with pseudoakathisia had both parkinsonism and TD, and 4 patients had only pseudoakathisia without being accompanied by other movement disorders. The demographic variables and the Manchester Scale score were not different among the groups. No significant group differences were found regarding the concurrence rate of parkinsonism or TD. In correlation analysis, BARS motor manifestation score was significantly correlated with AIMS total and limb-truncal dyskinesia scores, but not with AIMS orofacial dyskinesia score and SAS total score. Subjective restlessness score of BARS was significantly correlated with SAS total score but not with AIMS scores.
Conclusion：The results of the present study showed that the prevalence of pseudoakathisia in chronic schizophrenic in-patients receiving haloperidol or chlorpromazine was 8.2%. In clinical characteristics, pseudoakathisia with both parkinsonism and TD may exist. The relationship between pseudoakathisia and TD may be relatively limited. Further studies are required to elucidate more detailed characteristics of pseudoakathisia, and to examine its relationship with various clinical variables.
목차
서론
대상 및 방법
결과
고찰
결론
참고문헌
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
입원중(入院中)인 정신분열병(精神分裂病) 환자(患者)에서 지연성(遲延性) 운동장애(運動障碍)의 유병솔(有病率)
생물정신의학
2003 .01
-
Plasma Concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients
대한임상약리학회 학술대회
2001 .01
-
지연성 운동장애와 5-$HT_{2A}$ 수용체 유전자 T103C 다형성과의 관계
생물정신의학
2003 .01
-
HALOPERIDOL로 치료중인 정신분열병 환자에서 RIFAMPIN 병용 및 금단이 HALOPERIDOL 혈중농도 및 임상상태에 미치는 영향
대한임상약리학회 학술대회
1993 .01
-
지연성 운동장애와 BDNF(Brain-derived Neurotrophic Factor) Val66Met 유전자 다형성과의 연관성연구
생물치료정신의학
2006 .06
-
백서에서 Chlorpromzaine, Haloperidol, Clozapine이 뇌파에 미치는 영향
생물치료정신의학
2000 .06
-
정신분열병환자에서 만발성 운동장애와 $5-HT_6$ 수용체 유전자 다형성(267C/T)과의 관계
생물정신의학
2004 .01
-
SERUM HALOPERIDOL LEVEL AND CLINICAL EFFECTS IN CHRONIC SCHIZOPHRENIA
대한임상약리학회 학술대회
1993 .01
-
지연성 진전 1례
생물정신의학
1995 .01
-
지연성 운동장애와 CAG 반복 확장
신경정신의학
2002 .01
-
약인성 파킨슨증후군 환자의 한방 치험 1례
대한한방내과학회지
2016 .01
-
Oral Appliance as a Sensory Trick to Manage Tardive Dyskinesia of Tongue: A Case Report
Journal of Oral Medicine and Pain
2020 .06
-
산소중독에 대한 Glutathione과 Chlorpromazine의 보호효과에 관한 실험적 연구
한국독성학회지
1990 .12
-
No Evidence for an Association between Dopamine D2 Receptor Polymorphisms and Tardive Dyskinesia in Korean Schizophrenia Patients
PSYCHIATRY INVESTIGATION
2011 .01
-
The Association between Tardive Dyskinesia Induced by Haloperidol and Polymorphismsin the Serotonin Transporter Gene and Catecholamine-O- Methyltransferase Gene in KoreanSchizophrenic Patients
Clinical Psychopharmacology and Neuroscience
2005 .01
-
조등산(Diaoteng-san, Choto-san, 釣藤散)과 GB34(陽陵泉) 전침치료를 활용한 약인성파킨슨증후군 환자의 증례 1례
대한한방내과학회지
2017 .01
-
Effects of Fluoxetine Added to Haloperidol in Chronic Schizophrenic Patients
대한임상약리학회 학술대회
1996 .01
-
정상 성인에서 Haloperidol이 정신생리적 기능에 미치는 영향
생물치료정신의학
1996 .12
-
Haloperidol과 bethanechol 병합사용시 혈장 haloperidol 및 reduced haloperidol 농도에 미치는 영향
생물정신의학
1998 .01
-
Family Functioning and Communication in Spouses of Patients with Parkinsonism
Korean Journal of Family Medicine
2017 .01
이 논문의 저자 정보
이 논문과 함께 이용한 논문
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2009-513-018620441